Neeraj Sharma

Array ( [id] => 12253110 [patent_doc_number] => 09925239 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-27 [patent_title] => 'Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein' [patent_app_type] => utility [patent_app_number] => 14/861292 [patent_app_country] => US [patent_app_date] => 2015-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 10331 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14861292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16665129 [patent_doc_number] => 10934362 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-02 [patent_title] => Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof [patent_app_type] => utility [patent_app_number] => 15/511176 [patent_app_country] => US [patent_app_date] => 2015-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 62002 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11729330 [patent_doc_number] => 20170190773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'LIGANDS THAT POTENTIATE THE BIOACTIVITY OF GONADOTROPINS' [patent_app_type] => utility [patent_app_number] => 15/510492 [patent_app_country] => US [patent_app_date] => 2015-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17424 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15606233 [patent_doc_number] => 10584166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-10 [patent_title] => Ligands that potentiate the bioactivity of gonadotropins [patent_app_type] => utility [patent_app_number] => 15/510640 [patent_app_country] => US [patent_app_date] => 2015-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 23 [patent_no_of_words] => 18181 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12001878 [patent_doc_number] => 20170306034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'METHODS OF TREATING AUTOIMMUNE DISEASE USING A DOMAIN ANTIBODY DIRECTED AGAINST CD40L' [patent_app_type] => utility [patent_app_number] => 15/510507 [patent_app_country] => US [patent_app_date] => 2015-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12133 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16413256 [patent_doc_number] => 10821117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => Estrogen therapy for brain gray matter atrophy and associated disability [patent_app_type] => utility [patent_app_number] => 15/507863 [patent_app_country] => US [patent_app_date] => 2015-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26205 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11980887 [patent_doc_number] => 20170285041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'Method for determining risk of pre-eclampsia' [patent_app_type] => utility [patent_app_number] => 15/508135 [patent_app_country] => US [patent_app_date] => 2015-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6652 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12000061 [patent_doc_number] => 20170304216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 15/507881 [patent_app_country] => US [patent_app_date] => 2015-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 33316 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11618339 [patent_doc_number] => 20170128527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'PROLACTIN RECEPTOR ANTAGONISTS FOR TREATMENT OF GLIOBLASTOMA' [patent_app_type] => utility [patent_app_number] => 15/317683 [patent_app_country] => US [patent_app_date] => 2015-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4510 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 44 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10388013 [patent_doc_number] => 20150273020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'Hormone Normalization Therapy and Uses Therefor' [patent_app_type] => utility [patent_app_number] => 14/739333 [patent_app_country] => US [patent_app_date] => 2015-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 27937 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14739333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13081701 [patent_doc_number] => 10060914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-28 [patent_title] => Methods for separating cells [patent_app_type] => utility [patent_app_number] => 15/317494 [patent_app_country] => US [patent_app_date] => 2015-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 8333 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11541684 [patent_doc_number] => 20170095510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-06 [patent_title] => 'USE OF NANOPARTICLES COATED WITH RED BLOOD CELL MEMBRANES TO TREAT HEMOLYTIC DISEASES AND DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/315709 [patent_app_country] => US [patent_app_date] => 2015-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14239 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10437131 [patent_doc_number] => 20150322142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-12 [patent_title] => 'ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAME' [patent_app_type] => utility [patent_app_number] => 14/711705 [patent_app_country] => US [patent_app_date] => 2015-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 63394 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14711705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10807843 [patent_doc_number] => 20160154002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-02 [patent_title] => 'METHOD OF PREDICTING ANIMAL LITTER SIZE USING PROTEIN BIOMARKERS RELATED WITH FERTILITY, AND METHOD OF PREDICTING ANIMAL SPERM QUALITY AND LITTER SIZE USING CHLORTETRACYCLINE STAINING' [patent_app_type] => utility [patent_app_number] => 14/711741 [patent_app_country] => US [patent_app_date] => 2015-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13169 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14711741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11527237 [patent_doc_number] => 20170087214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-30 [patent_title] => 'FOLLICLE STIMULATING HORMONE SUPERAGONISTS' [patent_app_type] => utility [patent_app_number] => 14/710279 [patent_app_country] => US [patent_app_date] => 2015-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 16621 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14710279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11486198 [patent_doc_number] => 09592258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-14 [patent_title] => 'Treatment of neurological injury by administration of human umbilical cord tissue-derived cells' [patent_app_type] => utility [patent_app_number] => 14/705680 [patent_app_country] => US [patent_app_date] => 2015-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 104 [patent_no_of_words] => 41613 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14705680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10348899 [patent_doc_number] => 20150233904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'DETECTION OF NEUROLOGICAL DISEASES VIA MEASUREMENT OF NEUROMELANIN IN RECIRCULATING PHAGOCYTES' [patent_app_type] => utility [patent_app_number] => 14/704791 [patent_app_country] => US [patent_app_date] => 2015-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17552 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14704791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11491482 [patent_doc_number] => 20170065667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'METHODS FOR SYNCHRONIZATION OF ESTROUS CYCLES AND OVULATION FOR FIXED TIME ARTIFICIAL INSEMINATION IN CATTLE' [patent_app_type] => utility [patent_app_number] => 14/699904 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10843 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10346182 [patent_doc_number] => 20150231188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'MEDICAL FOOD FOR FETAL HEALTH DURING GESTATION' [patent_app_type] => utility [patent_app_number] => 14/696407 [patent_app_country] => US [patent_app_date] => 2015-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4154 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14696407 [rel_patent_id] =>[rel_patent_doc_number] =>)